', 'auto', 'clientTracker'); ga('clientTracker.send', 'pageview');
Jul 13, 2020
Dr. Pawel Soluch is the founder and CEO of Neuro Device Group S.A. He completed his PhD in the field of functional brain research from the University of Warsaw. Neuro Device focuses on wearable devices to mitigate the limitations aphasia presents as well as olfactory devices that can provide data on olfactory sensor activity. In this episode, Dr. Soluch speaks about the ways Neuro Device is developing devices that can predict the onset of Alzheimer’s and help overcome speech impairments.
Top three takeaways:
[0:00] Ladan introduces the episode and the guest, Dr. Pawel Soluch.
[2:20] Soluch discusses his beginnings in neurotech as a PhD student and why he decided to create Neuro Device.
[5:15] Their team has goals to create an invasive and non-invasive stimulator in relation to neurostimulation to prevent aphasia.
[8:30] Aphasia can have more negative impacts on the quality of life than symptoms associated with cancer or Alzheimer’s.
[10:15] The Neuro Device Voic allows therapists to build their own exercise programs on the model, making it adaptable to different languages.
[12:30] The devices use applications of oscillating electrical currents to influence cortical excitability and activity.
[15:25] The global pandemic has caused a pause on the progress of the olfactory device project while the Voic device is developing in hardware and software.
[18:10] The company has grown to be a success including 30 people partnering with leaders in science and medical device technology.
[21:35] The scent project in development could be used as an effective tool for the early diagnosis of diseases like Alzheimer’s.